Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 10, 2025 09:20 ET | Source: Ocugen

Ocugen CEO to Present at Oppenheimer Movers in Rare Disease Summit

MALVERN, Pa., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that...
December 09, 2025 07:00 ET | Source: ONL Therapeutics

ONL Therapeutics Announces Publication of Data from Phase 1b Study of Xelafaslatide, an Investigational Therapy for Geographic Atrophy, in Ophthalmology Science

ANN ARBOR, Mich., Dec. 09, 2025 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
December 08, 2025 19:43 ET | Source: RetinalGeniX Technologies, Inc.

RetinalGenix Technologies Agrees To Hire M. Cory Zwerling as CFO, Interim COO

RetinalGenix signs agreement to hire M. Cory Zwerling as its chief financial officer and interim chief operating officer, effective January 1, 2026
December 08, 2025 11:22 ET | Source: Research and Markets

Global Ophthalmology Market Set to Reach $94.36 Billion by 2030: AI and Personalized Care Drive Growth

Dublin, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The "Ophthalmology Market - Global Forecast 2025-2030" has been added to ResearchAndMarkets.com's offering.The global ophthalmology market is evolving...
December 05, 2025 07:26 ET | Source: Research and Markets

U.S. AI-Driven Retinal Screening Device Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

Dublin, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The "U.S. AI-Driven Retinal Screening Device Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to ...
December 02, 2025 08:00 ET | Source: Alkeus Pharmaceuticals

Alkeus Pharmaceuticals Appoints Renowned Retina Specialist and Biotech Executive Carlos Quezada-Ruiz, M.D., F.A.S.R.S., as Chief Medical Officer

Alkeus Pharmaceuticals appoints renowned retina specialist and biotech executive Carlos Quezada-Ruiz, M.D., F.A.S.R.S., as Chief Medical Officer
November 25, 2025 11:22 ET | Source: Research and Markets

Dry (Atrophic) Macular Degeneration Global Clinical Trials Market Review 2025: Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status

Dublin, Nov. 25, 2025 (GLOBE NEWSWIRE) -- The "Dry (Atrophic) Macular Degeneration - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.The...
November 20, 2025 07:58 ET | Source: BCC Research LLC

Global Hyaluronic Acid in Healthcare Market to Reach $10.5 Billion by 2030

Boston, Nov. 20, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Hyaluronic Acid in Healthcare: Global Markets” is projected to grow from $8 billion in 2025 to $10.5...
November 19, 2025 09:57 ET | Source: Cellution Biologics

Cellution Biologics Inc. Announces U.S. Launch of AmnioPlast 1 and AmnioPlast Double for Ocular Surface Repair

Cellution Biologics launches AmnioPlast 1 and AmnioPlast Double, aseptic amnion grafts advancing ocular surface repair and regenerative care.
November 19, 2025 08:56 ET | Source: Research and Markets

Blepharitis Market Analysis and Forecast Report 2025-2035 Featuring Tarsus Pharmaceuticals, Valeant Pharmaceuticals, Azura Ophthalmics, and Attillaps Pharmaceuticals

Dublin, Nov. 19, 2025 (GLOBE NEWSWIRE) -- The "Blepharitis Market - A Global and Regional Analysis: Focus on Regional and Country Analysis - Analysis and Forecast, 2025-2035" report has been added...